Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.5499
-0.0188 (-3.31%)
At close: Oct 13, 2025, 4:00 PM EDT
0.5896
+0.0397 (7.22%)
After-hours: Oct 13, 2025, 6:16 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $47.51 million as of October 13, 2025. Its market cap has decreased by -63.35% in one year.
Market Cap
47.51M
Enterprise Value
-56.59M
1-Year Change
-63.35%
Ranking
Category
Stock Price
$0.55
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $47.51M, a decrease of -95.48%. That is a compound annual growth rate of -51.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 49.13M | -42.79% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | 1.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |